The UK Medicines and Healthcare Products Regulatory Agency (MHRA) has completed a successful audit of Cobra Biomanufacturing’s facility in Keele. The authorization followed a three-day inspection and evaluation of the company’s manufacturing, analytical and quality management systems, which demonstrated that the facilities meet cGMP standards. Simon Saxby, chief executive officer of Cobra Biomanufacturing, said, “This is excellent news and ongoing confirmation of the commitment of the company...